Stenocare AS (CO:STENO) — Market Cap & Net Worth
Market Cap & Net Worth: Stenocare AS (STENO)
Stenocare AS (CO:STENO) has a market capitalization of $5.80 Million (Dkr37.06 Million) as of September 23, 2026. Listed on the CO stock exchange, this Denmark-based company holds position #28408 globally and #136 in its home market, demonstrating a -6.74% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Stenocare AS's stock price Dkr0.86 by its total outstanding shares 43195978 (43.20 Million). Also see STENO asset base for a full breakdown of the balance sheet.
Stenocare AS Market Cap History: 2020 to 2026
Stenocare AS's market capitalization history from 2020 to 2026. Data shows change from $132.73 Million to $5.80 Million (-44.35% CAGR). Also see STENO operating cash flow for how efficiently the company converts equity into cash flow.
Stenocare AS Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Stenocare AS's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Stenocare AS (STENO) stock price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
1.42x
Stenocare AS's market cap is 1.42 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $132.73 Million | $198.45K | -$11.79 Million | 668.85x | N/A |
| 2021 | $69.88 Million | $1.57 Million | -$12.73 Million | 44.37x | N/A |
| 2022 | $62.11 Million | $4.49 Million | -$16.30 Million | 13.83x | N/A |
| 2023 | $17.17 Million | $3.76 Million | -$17.57 Million | 4.57x | N/A |
| 2024 | $8.79 Million | $2.23 Million | -$34.49 Million | 3.94x | N/A |
| 2025 | $10.00 Million | $7.02 Million | -$2.39 Million | 1.42x | N/A |
Competitor Companies of STENO by Market Capitalization
Companies near Stenocare AS in the global market cap rankings as of September 23, 2026. Review Stenocare AS (STENO) tangible equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Stenocare AS by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #524 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #586 globally with a market cap of $46.44 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #638 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #651 globally with a market cap of $42.68 Billion USD ( CN¥291.65 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #524 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #586 | GALDERMA GROUP AG | NYSE:GALDY | $46.44 Billion | $39.83 |
| #638 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €16.50 |
| #651 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $42.68 Billion | CN¥45.72 |
Stenocare AS Historical Marketcap From 2020 to 2026
Between 2020 and today, Stenocare AS's market cap moved from $132.73 Million to $ 5.80 Million, with a yearly change of -44.35%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Dkr5.80 Million | -42.03% |
| 2025 | Dkr10.00 Million | +13.85% |
| 2024 | Dkr8.79 Million | -48.82% |
| 2023 | Dkr17.17 Million | -72.36% |
| 2022 | Dkr62.11 Million | -11.12% |
| 2021 | Dkr69.88 Million | -47.35% |
| 2020 | Dkr132.73 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 23rd, 2026 the market cap of Stenocare AS was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $5.80 Million USD |
| MoneyControl | $5.80 Million USD |
| MarketWatch | $5.80 Million USD |
| marketcap.company | $5.80 Million USD |
| Reuters | $5.80 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Stenocare AS
Stenocare A/S cultivates, produces, imports, distributes, and sells prescription-based medical cannabis products to patients in Denmark and internationally. It offers medical cannabis oil products, including THC, THC/CBD, and CBD, as well as CBD100 oil products. The company was incorporated in 2017 and is based in Randers, Denmark.